NM_004463.3:c.1328G>A
Variant summary
Our verdict is Likely pathogenic. The variant received 9 ACMG points: 9P and 0B. PM2PM5PP3_StrongPP5
The NM_004463.3(FGD1):c.1328G>A(p.Arg443His) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 13/21 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R443L) has been classified as Pathogenic.
Frequency
Consequence
NM_004463.3 missense
Scores
Clinical Significance
Conservation
Publications
- Aarskog-Scott syndrome, X-linkedInheritance: AD, XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), G2P, ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Likely_pathogenic. The variant received 9 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| FGD1 | NM_004463.3 | c.1328G>A | p.Arg443His | missense_variant | Exon 6 of 18 | ENST00000375135.4 | NP_004454.2 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 22
GnomAD4 exome Data not reliable, filtered out with message: AC0 AF: 0.00 AC: 0AN: 1054556Hom.: 0 Cov.: 31 AF XY: 0.00 AC XY: 0AN XY: 345024
GnomAD4 genome Cov.: 22
ClinVar
Submissions by phenotype
not provided Pathogenic:2
Published functional studies suggest a damaging effect on downstream signaling (PMID: 21965325); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 20082460, 21739585, 14560308, 17847065, 24770546, 21965325, 38299177) -
FGD1: PM2, PM5:Supporting, PP2, PP3, PP4, PS4:Supporting -
Aarskog syndrome Pathogenic:2
- -
PM3, PM2, PP3, PM5, PP2 -
Inborn genetic diseases Pathogenic:1
- -
not specified Uncertain:1
Variant summary: FGD1 c.1328G>A (p.Arg443His) results in a non-conservative amino acid change located in the Dbl homology (DH) domain (IPR000219) of the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The frequency data for this variant in gnomAD is considered unreliable, as metrics indicate poor data quality at this position. c.1328G>A has been reported in the literature in an individual affected with Aarskog Syndrome (Orrico_2004). These data do not allow any conclusion about variant significance. At least one publication reports experimental evidence evaluating an impact on protein function. The most pronounced variant effect results in about 45% reduction in phosphorylation of the downstream target MLK3 and Runx2-responsive OG2-luc activity (Zou_2011). The following publications have been ascertained in the context of this evaluation (PMID: 14560308, 21965325). ClinVar contains an entry for this variant (Variation ID: 521263). Based on the evidence outlined above, the variant was classified as VUS-possibly pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at